Author

Olga Syrkina

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Immunogenicity and Safety of Single-Dose MenACYW Conjugate Vaccine in Vietnamese Participants Aged ≥ 12 Months: A Phase III, Open-Label Study.

INTRODUCTION Invasive meningococcal disease (IMD) is a progressive condition commonly presenting as septicemia and meningitis, with significant mortality and morbidity. Vietnam reports high incidence rates among military populations and young infants. Despite this burden and unpredictable outbreaks, meningococcal vacci...

Thiem Dinh Vu, Stephane Janicot, Olga Syrkina et al. · Infectious Disease and Thera... · 0 citations

Review Open access Aug 2026

Narrative review of the clinical safety of MenACYW-TT: a quadrivalent meningococcal vaccine conjugated to tetanus toxoid licensed in the US and abroad.

INTRODUCTION Routine meningococcal vaccination campaigns have substantially reduced the burden of invasive meningococcal disease in pediatric individuals, leading to relative increases in burden in older age groups. There is a need for safe, effective meningococcal vaccines that can be used across broad age ranges. Men...

Olga Syrkina, M. Bausch-Jurken, Arlette Delgado et al. · Expert Review of Vaccines · 0 citations

Clinical trial Open access Aug 2026

Safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in USA and Puerto Rico: Results from a Phase III, randomized, active-controlled study

This study supports the safety profile of MenACYW-TT in infants and toddlers aged ≥ 6 weeks and overall well tolerated, and safety profiles were comparable.

Abraham Moskow, Sandeep Gupta, M. Dhingra et al. · Human Vaccines & Immunothera... · 0 citations